Schizophrenia shows a unique metabolomics signature in plasma

Schizophrenia is a severe complex mental disorder affecting 0.5–1% of the world population. To date, diagnosis of the disease is mainly based on personal and thus subjective interviews. The underlying molecular mechanism of schizophrenia is poorly understood. Using targeted metabolomics we quantifie...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Y, Yu, Z, Giegling, I, Xie, L, Hartmann, A M, Prehn, C, Adamski, J, Kahn, R, Li, Y, Illig, T, Wang-Sattler, R, Rujescu, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432190/
https://www.ncbi.nlm.nih.gov/pubmed/22892715
http://dx.doi.org/10.1038/tp.2012.76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432190/
https://www.ncbi.nlm.nih.gov/pubmed/22892715
http://dx.doi.org/10.1038/tp.2012.76

Ejemplares similares